Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115550) titled 'Screening and identification of biomarkers for differentiating benign and malignant pulmonary nodules using multi-omics technologies' on Dec. 29, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Taizhou Central Hospital (Taizhou University Hospital)
Condition:
Pulmonary Nodules
Intervention:
Healthy Control Group:Not Available
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2023-04-11
Target Sample Size: Healthy Control Group:50;Pulmonary Nodules Group:950;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.h...